Home/ Stocks/ QNRX

Quoin Pharmaceuticals, Ltd. American Depositary Shares

QNRX XNAS

$4.79 +0.22 (+4.81%) ▲ 15-min delayed

Open

$4.79

High

$4.90

Low

$4.70

Volume

17.4K

Market Cap

$9.18M

About Quoin Pharmaceuticals, Ltd. American Depositary Shares

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 6 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	N/A	$-4,997,735	N/A
FY 2025	N/A	$-15,804,655	N/A
Q3 2025	N/A	$-3,948,165	N/A
Q2 2025	N/A	$-3,695,938	N/A

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for QNRX yet. Check out our latest market news or earnings calendar.

Get QNRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Quoin Pharmaceuticals, Ltd. American Depositary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.